Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-097-4 | CAS number: 37353-75-6 1 - 4.5 moles propoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
In vivo skin irritation testing was performed that did not show the test substance to be corrosive to the skin. An in vitro skin irritation study was performed in accordance with the OECD Testing Guideline 439 on the registered substance and concluded that it meets the criteria for classification as irritant to the skin.
An in vitro eye irritation study was performed in accordance with the OECD Testing Guideline 437 on the registered substance and concluded it does not meet the criteria for classification as damaging or irritant to the eye.
In vivo testing was performed before the implementation of REACH for the purpose of other regulations and therefore is not in breach of the Animal Welfare Legislation.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- Principles of method if other than guideline:
- EPISKIN Skin Irritation Test-42 Hours
- GLP compliance:
- yes
- Species:
- human
- Strain:
- other: Three dimensional human skin model
- Details on test animals or test system and environmental conditions:
- The test involves the application of the test substance for 15 minutes to the EPISKIN threedimensional human skin model. The model consists of normal, human-derived epidermal keratinocytes which have been seeded on a dermal substitute consisting of a collagen type 1 matrix coated with type IV collagen. After 13 days in culture a multilayered, highly differentiated model of the human epidermis with a functional multi-layered stratum corneum has formed. The epidermis surface area supplied is 0.38 cm^2. The EPISKIN kits include assay medium, maintenance medium, 12 well plates and the tissues which are shipped on nutritive agar.
- Type of coverage:
- other: In vitro
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- The test substance, positive and negative controls were in liquid form and were applied by dispensing a volume of 10 µl over each tissue using a positive displacement pipette.
- Duration of treatment / exposure:
- Exposure over 15 minutes.
- Number of animals:
- N/A
- Irritation / corrosion parameter:
- % tissue viability
- Value:
- 14.3
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other:
- Remarks:
- Basis: mean. Remarks: +/- 2.7 %
- Interpretation of results:
- Category 2 (irritant) based on GHS criteria
- Conclusions:
- In vitro skin irritation using the EPISKIN method gave a moderately irritating response.
- Executive summary:
The skin irritation potential of the test substance was determined in vitro using the EPISKIN human epidermis model. The test substance was applied to EPISKIN human epidermis skin constructs. The constructs consisted of normal, human-derived epidermal keratinocytes, which had been cultured to form a multilayered, highly differentiated model of the human epidermis with a functional multilayered stratum corneum. The cell viability of the multi layers was determined by mitochondrial dehydrogenase activity. The prediction model uses the percentage viability values (compared to negative control viability) to identify irritant and non-irritant substances. The test substance elicited a mean tissue viability of 14.3 ± 2.7% and was predicted as irritant.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Species:
- other: bovine
- Strain:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Duration of treatment / exposure:
- 60 minutes
- Number of animals or in vitro replicates:
- No number given, multiple corneas used.
- Irritation parameter:
- in vitro irritation score
- Value:
- -1
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Irritant classification non corrosive/non severe
- Executive summary:
Further animal testing is not considered appropriate.
Reference
Results of control test
Opacity +/- SD | Permeability +/- SD | In Vitro Irritancy Score |
Irritant Classification | |
Positive Control | 245 +/- 7.371 | 2.118 +/- 0.111 | 276.8 +/- 7.6 | Corrosive/Severe |
Negative Control | 2.333 +/- 2.309 | 0. 009 +/- 0.001 | N/A | N/A |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The substance was irritating to skin but not irritating to eyes during in vitro testing. The low water solubility will have reduced exposure to the surface of the excised eye used in the eye study, but otherwise, there is no clear reason why irritation to eyes appears less than to skin.
Justification for selection of skin irritation / corrosion endpoint:
The key study was conducted on the registered substance at a GLP accredited laboratory according to revised OECD Testing Guideline 404.
Justification for selection of eye irritation endpoint:
The study was conducted on the registered substance at a GLP accredited laboratory according to OECD Testing Guideline 437.
Effects on skin irritation/corrosion: moderately irritating
Justification for classification or non-classification
In vivo skin irritation testing allowed to demonstrate that the registered substance is not corrosive to the skin. In vitro irritation testing performed on the registered substance according to appropriate OECD Guidelines concluded that it meets the criteria for classification as irritant to the skin but not as damaging or irritant to the eye.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.